000 01677 a2200421 4500
005 20250512055940.0
264 0 _c19861117
008 198611s 0 0 eng d
022 _a0095-1137
024 7 _a10.1128/jcm.24.3.336-342.1986
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGorse, G J
245 0 0 _aSafety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
_h[electronic resource]
260 _bJournal of clinical microbiology
_cSep 1986
300 _a336-42 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Intranasal
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Viral
_xbiosynthesis
650 0 4 _aChronic Disease
650 0 4 _aClinical Trials as Topic
650 0 4 _aCold Temperature
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHemagglutination Inhibition Tests
650 0 4 _aHumans
650 0 4 _aImmunoglobulin A
_xbiosynthesis
650 0 4 _aImmunoglobulin G
_xbiosynthesis
650 0 4 _aInfluenza A virus
_ximmunology
650 0 4 _aInfluenza Vaccines
_xadministration & dosage
650 0 4 _aInfluenza, Human
_xprevention & control
650 0 4 _aMiddle Aged
650 0 4 _aVaccines, Attenuated
700 1 _aBelshe, R B
700 1 _aMunn, N J
773 0 _tJournal of clinical microbiology
_gvol. 24
_gno. 3
_gp. 336-42
856 4 0 _uhttps://doi.org/10.1128/jcm.24.3.336-342.1986
_zAvailable from publisher's website
999 _c3536950
_d3536950